p53 Mutation Lung Cancer: VCU Achilles' Heel | AcademicJobs
VCU Massey researchers uncover a key weakness in p53 mutations driving lung cancer, paving the way for targeted therapies via checkpoint inhibitors.
No reviews yet. Be the first to rate Shilpa!
VCU Massey researchers uncover a key weakness in p53 mutations driving lung cancer, paving the way for targeted therapies via checkpoint inhibitors.